Table 1 Clinicopathological variables of patients with spindle cell variant of medullary thyroid carcinoma
From: Spindle cell variant of medullary thyroid carcinoma: a clinicopathologic study of four cases
Case | Sex | Age | Tumor site | Tumor size (cm) | Histological type | Immunophenotype | Recurrence | Follow-up (months) | Status |
|---|---|---|---|---|---|---|---|---|---|
1 | F | 54 | LLT | 2 × 2 × 2.5 | spindle cell variant MTC | CT+, CgA +, Syn+, CD56+, TTF-1+, TG-, AE1/AE3+, Ki-67+ (5%) | _ | 60 | Alive |
2 | M | 26 | RLT | 6 × 3× 3 | spindle cell variant MTC | CT+, CgA +, Syn+, CD56+, TTF-1+, TG-, CEA+, AE1/AE3+, SMA-, S-100-,HMB45-, CD99-, Ki-67+ (5%) | _ | 7 | Alive |
3 | F | 49 | LLT | 4 × 2× 2 | spindle cell variant MTC | CT+, CgA +, Syn+, CD56+, TTF-1+, TG-, CEA+, vimentin+, SMA-, S-100-, HBME-1-, galectin-3-, CK19-, Ki-67+ (3%) | _ | 84 | Alive |
4 | M | 51 | RLT | 2.4 × 1.6 × 2.2 | spindle cell variant MTC | CT+, CgA +, Syn+, CD56+,TTF-1+, TG-, CEA+ EMA+,vimentin+, SMA-, S-100-, HBME-1-, Ki-67+ (10%) | _ | 72 | Alive |